Mitral regurgitation is a cardiac ailment characterized by the retrograde flow of blood from the left ventricle back into the left atrium. The mitral valve, responsible for maintaining the unidirectional flow of blood between these cardiac chambers, fails to close properly during each heartbeat, leading to the regurgitation or leakage of blood. This condition imposes an increased workload on the heart as it endeavors to pump an adequate volume of blood to meet the body's physiological demands. Diverse etiological factors contribute to the development of mitral regurgitation, including mitral valve prolapse, rheumatic heart disease, and congenital anomalies. The manifestation of symptoms often includes fatigue, dyspnea (shortness of breath), and the presence of a discernible heart murmur upon auscultation. An early and accurate diagnosis is imperative for instituting timely interventions, as this can help prevent potential complications associated with untreated mitral regurgitation. In the realm of management, various strategies are employed to address this cardiovascular condition. Medical interventions, including pharmacotherapy, play a crucial role in alleviating symptoms and improving heart function. In instances of severe mitral regurgitation, surgical options such as repair or replacement of the mitral valve may be considered to restore normal cardiac function. The choice of intervention is often tailored to the severity of the condition and the individual patient's health status.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt